DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Prins MH. et al.
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials.
Lancet Haematol 2014;
01: e37-e46.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.